These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38145378)

  • 1. CRISPR-Cas-mediated Multianalyte Synthetic Urine Biomarker Test for Portable Diagnostics.
    Van Heest AE; Deng F; Zhao RT; Harzallah NS; Fleming HE; Bhatia SN; Hao L
    J Vis Exp; 2023 Dec; (202):. PubMed ID: 38145378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR-Cas-amplified urinary biomarkers for multiplexed and portable cancer diagnostics.
    Hao L; Zhao RT; Welch NL; Tan EKW; Zhong Q; Harzallah NS; Ngambenjawong C; Ko H; Fleming HE; Sabeti PC; Bhatia SN
    Nat Nanotechnol; 2023 Jul; 18(7):798-807. PubMed ID: 37095220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR/Cas-powered nanobiosensors for diagnostics.
    Phan QA; Truong LB; Medina-Cruz D; Dincer C; Mostafavi E
    Biosens Bioelectron; 2022 Feb; 197():113732. PubMed ID: 34741959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Point-of-care diagnostics for noncommunicable diseases using synthetic urinary biomarkers and paper microfluidics.
    Warren AD; Kwong GA; Wood DK; Lin KY; Bhatia SN
    Proc Natl Acad Sci U S A; 2014 Mar; 111(10):3671-6. PubMed ID: 24567404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanozyme-catalysed CRISPR assay for preamplification-free detection of non-coding RNAs.
    Broto M; Kaminski MM; Adrianus C; Kim N; Greensmith R; Dissanayake-Perera S; Schubert AJ; Tan X; Kim H; Dighe AS; Collins JJ; Stevens MM
    Nat Nanotechnol; 2022 Oct; 17(10):1120-1126. PubMed ID: 35927321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR-Cas system manipulating nanoparticles signal transduction for cancer diagnosis.
    Guo Y; Guo L; Su Y; Xiong Y
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023 Mar; 15(2):e1851. PubMed ID: 36199268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiplexed CRISPR-Based Nucleic Acid Detection Using a Single Cas Protein.
    Fu J; Zhang L; Long Y; Liu Z; Meng G; Zhao H; Su X; Shi S
    Anal Chem; 2023 Nov; 95(44):16089-16097. PubMed ID: 37883656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantum Dot-Based Molecular Beacons for Quantitative Detection of Nucleic Acids with CRISPR/Cas(N) Nucleases.
    Green CM; Spangler J; Susumu K; Stenger DA; Medintz IL; Díaz SA
    ACS Nano; 2022 Dec; 16(12):20693-20704. PubMed ID: 36378103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanistic insights of CRISPR/Cas nucleases for programmable targeting and early-stage diagnosis: A review.
    Habimana JD; Huang R; Muhoza B; Kalisa YN; Han X; Deng W; Li Z
    Biosens Bioelectron; 2022 May; 203():114033. PubMed ID: 35131696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid Visual CRISPR Assay: A Naked-Eye Colorimetric Detection Method for Nucleic Acids Based on CRISPR/Cas12a and a Convolutional Neural Network.
    Xie S; Tao D; Fu Y; Xu B; Tang Y; Steinaa L; Hemmink JD; Pan W; Huang X; Nie X; Zhao C; Ruan J; Zhang Y; Han J; Fu L; Ma Y; Li X; Liu X; Zhao S
    ACS Synth Biol; 2022 Jan; 11(1):383-396. PubMed ID: 34937346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recognition of DNA Target Formulations by CRISPR-Cas12a Using a dsDNA Reporter.
    Smith CW; Kachwala MJ; Nandu N; Yigit MV
    ACS Synth Biol; 2021 Jul; 10(7):1785-1791. PubMed ID: 34142793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas Advancement in Molecular Diagnostics and Signal Readout Approaches.
    Ahmed MZ; Badani P; Reddy R; Mishra G
    J Mol Diagn; 2021 Nov; 23(11):1433-1442. PubMed ID: 34454111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR/Cas12a linked sandwich aptamer assay for sensitive detection of thrombin.
    Zhu F; Zhao Q
    Anal Chim Acta; 2024 Jan; 1287():342106. PubMed ID: 38182384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR-Based Precision Molecular Diagnostics for Disease Detection and Surveillance.
    Kulkarni A; Tanga S; Karmakar A; Hota A; Maji B
    ACS Appl Bio Mater; 2023 Oct; 6(10):3927-3945. PubMed ID: 37788375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metal-Organic Framework-DNA Bio-Barcodes Amplified CRISPR/Cas12a Assay for Ultrasensitive Detection of Protein Biomarkers.
    Long W; Yang J; Zhao Q; Pan Y; Luan X; He B; Han X; Wang Y; Song Y
    Anal Chem; 2023 Jan; 95(2):1618-1626. PubMed ID: 36541937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional DNA Regulated CRISPR-Cas12a Sensors for Point-of-Care Diagnostics of Non-Nucleic-Acid Targets.
    Xiong Y; Zhang J; Yang Z; Mou Q; Ma Y; Xiong Y; Lu Y
    J Am Chem Soc; 2020 Jan; 142(1):207-213. PubMed ID: 31800219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Miniature CRISPR-Cas13 System for SARS-CoV-2 Diagnostics.
    Mahas A; Wang Q; Marsic T; Mahfouz MM
    ACS Synth Biol; 2021 Oct; 10(10):2541-2551. PubMed ID: 34546709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Capturing nucleic acid variants with precision using CRISPR diagnostics.
    Kumar M; Maiti S; Chakraborty D
    Biosens Bioelectron; 2022 Dec; 217():114712. PubMed ID: 36155952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhalable point-of-care urinary diagnostic platform.
    Zhong Q; Tan EKW; Martin-Alonso C; Parisi T; Hao L; Kirkpatrick JD; Fadel T; Fleming HE; Jacks T; Bhatia SN
    Sci Adv; 2024 Jan; 10(1):eadj9591. PubMed ID: 38181080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrinsic signal amplification by type III CRISPR-Cas systems provides a sequence-specific SARS-CoV-2 diagnostic.
    Santiago-Frangos A; Hall LN; Nemudraia A; Nemudryi A; Krishna P; Wiegand T; Wilkinson RA; Snyder DT; Hedges JF; Cicha C; Lee HH; Graham A; Jutila MA; Taylor MP; Wiedenheft B
    Cell Rep Med; 2021 Jun; 2(6):100319. PubMed ID: 34075364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.